The IT @ Networking Awards 2010

The goal of the IT @ Networking Awards 2010 (IT @ 2010), is to honour and promote outstanding healthcare IT solutions. The core aim of IT @ 2010 is to learn from the achievements of the very best IT installations on the globe.

Healthcare systems face unprecedented challenges: high-tech, high-cost medicine; ageing populations; increased patient mobility; staff shortages; and a financial crisis. Intelligent IT solutions increase cost-effectiveness, productivity and safety and help healthcare facilities to confront these problems.

IT @ 2010 brings these cutting edge innovations into the global spotlight and gives them the recognition and media attention they deserve. Their stories will inspire others, proving that challenges can be transformed into future opportunities and success stories.

The IT @ Networking Awards are founded on the belief that healthcare professionals, the daily users of IT solutions, are best placed to judge the value of new projects. Our unique peer to peer voting system empowers the attending healthcare professionals to vote for their preferred projects alongside the panel of expert judges.

MindByte
Out of all submissions, only the 25 best solutions will qualify to become a Nominee. They will be invited to present in the first round MindByte session and will be awarded the prestigious IT @ 2010 Nominee Medal.

Each MindByte includes a five minute introductory presentation followed by a five minute lively Q&A. The qualifying audience will vote immediately after each presentation based on the following criteria:

1. The Importance of Technology
What technology was used and how it was integrated into the workplace?

2. Benefits
Has the project helped those it was designed to help?
Has the project changed how tasks are performed?
What new advantage(s) or opportunities does the project provide?

3. Originality
What makes the solution special?
Are there any original features?
Is it the first, the only, the best or the most effective application of its kind?
Is it an improvement on existing implementations?

4. Difficulty
What were the most important obstacles that had to be overcome?
Were there any technical or organisational problems?

5. Success
Has the project achieved or exceeded its goals?
How do you see the project's success affecting other applications, your facility or other organisations?
How quickly would the users accept this innovation?

6. Impact
What is your overall impression of the project?
Would you consider implementing this IT solution in your healthcare facility?

WORKBENCH
Only the nine top-rated Nominees will progress as Finalists into the next day WORKBENCH. This is a 30-minute in-depth presentation followed by a lively 15-minute Q&A discussion, providing the audience with a thorough understanding of the project.

The qualifying audience will vote immediately after each presentation to choose the winners. Finalists will be awarded the prestigious IT @ Networking Awards 2010 Finalist Medal.

The Prize
Out of the finalists, the top three IT solutions will be awarded a prize.

The winning project will receive:

  • the IT @ Networking Awards 2010 Trophy;
  • a cash prize of Euro 5,000, this is the world's highest remunerated healthcare IT award, and
  • media promotion in Europe's leading healthcare management media worth Euro 50,000.

The second project will receive:

  • the IT @ Networking Awards 2010 Trophy;
  • media promotion in Europe's leading healthcare management media worth Euro 25,000.

The third project will receive:

  • the IT @ Networking Awards 2010 Trophy.

Project Submission
All entries must already be implemented in at least one site and must be fully operable. All projects must be presented in accordance to the voting criteria.

Submission deadline is 25 June 2010.

All project submissions will be presented to the IT @ 2010 Review Committee. This Review Committee will decide the top 25 IT solutions that will become Nominees and will take part in the MindByte Session.

Secure your presence now and take advantage of early bird registration until 31 May 2010.

For further information and registration, please visit:
http://www.hitm.eu

Most Popular Now

AstraZeneca divests rights for Losec to Cheplaphar…

AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arznei...

Bayer, Brigham and Women’s Hospital, and Massachus…

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to ...

Amgen announces positive results from two Phase 3 …

Amgen (NASDAQ:AMGN) today announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (2012021...

Cause of antibiotic resistance identified

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patient...

Brilinta monotherapy in high-bleeding risk patient…

New data from TWILIGHT, a Phase IV independent trial (funded by AstraZeneca), showed that in patients at high-bleeding risk who underwent PCI and completed 3 months of du...

Novartis and Microsoft announce collaboration to t…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science pa...

Bayer inks deals with eleven startups under G4A Di…

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup c...

Ian Read to retire as Executive Chairman of Pfizer…

Following its regularly scheduled meeting, the Board of Directors of Pfizer Inc. (NYSE:PFE) today announced that Executive Chairman of the Board Ian C. Read has chosen to...

Discovery of new source of cancer antigens may exp…

For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-...

Pharmacists provide patient value in team-based ca…

With inhaler in hand, Dr. Cheng Yuet went over every detail to make sure the patient understood how the drug would control their COPD symptoms. Dr. Yuet is proving what a...

Chinese activists protest the use of traditional t…

In the West, the number of people challenging scientific authority has been growing in past decades. This has, among other things, led to a decline in the support for mas...

AI and big data predict which research will influe…

An artificial intelligence/machine learning model to predict which scientific advances are likely to eventually translate to the clinic has been developed by Ian Hutchins...